Latest news
Biotech Firm Secures 39.9 Million Euro for Kidney Research - N24 HaberN24 Haber · Sat, 08 Aug 2026 23:16:26 GMTGlasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMTScottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 16:12:39 GMTMironid Secures $46m To Advance Rare Disease Therapeutics - eurekamagazine.co.ukeurekamagazine.co.uk · Wed, 05 Aug 2026 13:37:33 GMTMironid banks $46m in Series B to take rare kidney disease drug closer to clinic - Pharmaceutical TechnologyPharmaceutical Technology · Wed, 05 Aug 2026 11:02:58 GMTMironid raises $46M to push rare kidney disease drug into the clinic - DealroomDealroom · Wed, 05 Aug 2026 08:58:56 GMTRoche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 08:06:57 GMTMironid - Via RitzauVia Ritzau · Wed, 05 Aug 2026 06:00:00 GMT